chrisvoncsefalvay/vaers-outcomes huggingface dataset:
still feels fatigue\body is getting fatigued more often\fatigue comes and go\has a higher fatigue when moving compared to sitting; This spontaneous case was reported by a health care professional and describes the occurrence of FATIGUE (still feels fatigue\body is getting fatigued more often\fatigue comes and go\has a higher fatigue when moving compared to sitting) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (still feels fatigue\body is getting fatigued more often\fatigue comes and go\has a higher fatigue when moving compared to sitting). At the time of the report, FATIGUE (still feels fatigue\body is getting fatigued more often\fatigue comes and go\has a higher fatigue when moving compared to sitting) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: (Negative) No antibodies appeared in blood work after taking both doses.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history not provided. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up received on 29-MAY-2021. contain significant information include additional event and outcome mentioned that still experiencing events On 30-May-2021: Follow up received on 30-MAY-2021. No new information was added.
Leg swollen from upper thigh to knee. Red, hot to touch, painful to touch. Treatment: Benadryl.
Two days post vax the pt developed severe aches and pains, a flu like feeling and a low grade fever (highest at 101.4F). The pts symptoms persisted. The pt sought unspecified medical attention. Follow up information from a physician indicated that the pts fatigue symptoms persisted until 07/20/2000. The pt was treated with ibuprofen and acetomenaphin (+) hydrocodone bitartrate for body aches and fever. Subsequently the pt recovered.
Ten minutes after vaccine administration, employee started feeling very nauseated.  She became tachycardic and became very blotchy across her chest and left arm.  Employee was sent to the emergency room for evaluation.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 28-SEP-2012, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Headache: Pretty small and manageable. Started day of, continued for 2 days after vaccine.  Nausea: This one is the worst. Currently feeling it 3 days after vaccine, started day after.  Fatigue: Started day of, but may have been due to stress. Worsened next day, still there 3 days later.
I was fully vaccinated and on 4-11-22, I started having a scratchy/sore throat, cough, intense headache and my temperature spiked to 100.9, I felt fatigued and I could not concentrate. I had a poor appetite. I lost sense of taste for a short while. I felt like I could compare it to the flu. I had 3 home tests for COVID-19. The first was negative and the next two were positive on 4-14-22. I began feeling better by 4-16-22.
pt recvd vax & exp inject site pain & swelling p/dose 3; NOV93 exp upper body pain,weakness,fatigue;c/o pain in chest,back,arms;tires very easily;generalized musculoskeletal pain;rx w/naprosyn,pred,flexeril;diff driving,in physical therapy
4/3/09 Hx acting different, restless, low grade fever, crying, screaming with sucking, poor appetite, restless x 2 days. Onset 4/2/09. Assessment: Pallor, irritable, shrill cry at rest, increasing with any movement. Decreased spontaneous activity, staring gaze.  5/29/09 Received hospital medical records of 4/3-4/5/2009. FINAL DX: febrile illness; anorexia; irritability s/p immunizations. Records reveal patient experienced low grade fever, poor appetite, restlessness, inconsolable crying, abnormal behavior x 2 days.  Had exposure to family members w/sore throat.
Bronchitis with some fluid/mucus in lungs resulting in frequent, painful cough. Symptoms actually started one day prior to second dose and continued to worsen, prompting an urgent care visit. Experienced coughing fits and shortness of breath when active  Treated with 1 round of Z-pak (6/11-6/16, somewhat effective), 1 round of prednisone (6/22-current), with virtussin to suppress cough and al albuterol rescue inhaler.   Patient also had a concurrent rash/hives at onset, assumed to be an allergic reaction to a new soap. Treated with OTC antihistamines and aloe vera and went away on its own.
No Adverse Event; Nurse reported that VARIVAX was administered following temperature excursion. Consent to contact obtained. No additional AEs/PQCs reported.  ?    Names of vaccines involved (including lot/exp) VARIVAX  Lot: W031815  Exp: 10/5/2024         ?    Te; This spontaneous report was received from an other health professional refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 01-MAY-2023, the patient was vaccinated with the first dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot# W031815, expiration date: 05-OCT-2024 (exact dose, route of administration and anatomical location were not reported) for prophylaxis.   Administered dose of vaccine was exposed for the temperature excursion of 9 degrees Fahrenheit for 2 hours and 6 minutes.  No previous temperature excursion had occurred. There were no additional adverse events reported.
pt recv vax & p/shot lt arm was achy & devel a red spot;p/ 1/2hr became nauseated;w/in 1hr felt dizzy;@ present cont w/dizziness, lt arm is red, hot & tender;redness is approx size of an orange or apple;tx contact MD;advised ice & APAP;
Pt experienced facial clenching, eyes bulging, shoulder shrugging and right arm abduction for 10-15 seconds and then hypotonic collapse. Pt then returned to normal state before recurrence of symptoms. There was a decrease in frequency of the symptoms after 1-2 hours. Pt taken to ER. She had no cyanosis or breathing problems. Symptoms resolved by 12:30 AM. Afebrile seizure lasted about 4 hours with no treatment recvd at ER.
acute right basal ganglia hematoma with extension to the intraventricular area; right caudate nucleus and right corona radiata ischemic stroke; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 03-MAR-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiveing zoster vaccine live (ZOSTAVAX), the patient suffered  acute right basal ganglia hematoma with extension to the interventricular area, right caudate nucleus and right corona radiata ischemic stroke requiring hospitalization. As a direct and proximate result, the patient's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX), the patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. The patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.   Upon internal review, acute right basal ganglia hematoma with extension to the interventricular area, right caudate nucleus and right corona radiata ischemic stroke were considered medically significant.    The events were considered to be disabling due to the severe, permanent and incurable injuries.
Severe joint pain,  then chills rocking the bed chills, fever initial of 101.8 up to 102.6 for 2 days, severe nausea , cough, it was 5 days until I was free of all symptoms
client was awaken early morning 2 days after covid vaccine with severe abdominal cramps and nausea. Called PCP and got prescription for meclizine that afternoon and that helped alleviate symptoms along with taking zofran, which client already had at home.
Systems started later in the evening.   Dose was as 12:10pm.  About 6pm in the evening slight headache,  fatigue.   The next morning temperature of 100.2, headache,  fatigue and body aches.
Patient received 1st dose of SHINGRIX (shingles "non-live" attenuated vaccine) on 4/11/2018 approx. at 9:26AM, and per patient she started developing swelling and redness aprox 2 hrs. later (11:30AM). The swelling grew and spread from the injection site on Left upper arm(deltoid area) into the under arm pit area and even developed a red rash in the Left breast with skin peeling back. Area of swelling is bigger than a "baseball size" and very hard induration with very warm to found. Pt. advised to be seen at Clinic (appt made for 4/19 w/ PAC). Patient is icing/elevating and taking BENADRYL for which has been effective. 61 yo female presents to the clinic with complaint of red swelling on the left upper arm after receiving the SHINGRIX vaccination (shot #1) that was administered on 04/11/2018). She stated that the erythematous area on her left upper arm started in the anterior aspect, with the pain and swelling subsiding considerably after the use of diphenhydramine and cold pack applications. She subsequently developed a vesicular rash on the underside of her right breast that is responded very well to diphenhydramine. She states that she was having pain with a little bit of bleeding related to this rash, which peeled as well, stating that the pain now had dissipated considerably. She denies any shortness of breath (although she states that she did have pronounced fatigue and some sensation of having a hard time catching her breath). No angioedema expressed. She did describe an additional suspected adverse reaction after she received an injection into her right knee to help reduce swelling and inflammation (suspected to be a corticosteroid with or without and additional agent added). She states that the next day she developed a significant reddening of her face that was burning. She has also described symptoms of severe muscle pains, lightheadedness and dizziness, and near passing out when eating certain foods.
Sore throat; Chills; Fever; Tested COVID19 positive; Shortness of breath; Swelling in legs; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PERIPHERAL SWELLING (Swelling in legs), OROPHARYNGEAL PAIN (Sore throat), COVID-19 (Tested COVID19 positive) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Liver disorder (Liver disease).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling in legs). On 22-Jan-2021, the patient experienced COVID-19 (Tested COVID19 positive). On 23-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, DYSPNOEA (Shortness of breath), PERIPHERAL SWELLING (Swelling in legs), OROPHARYNGEAL PAIN (Sore throat), COVID-19 (Tested COVID19 positive), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: other (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Patient seen in clinic 1-20-08. Right Thigh with oval Area of inflammation at injection site.
Fever that reached 106, fussiness, loss of appetite.  Treatment: Tylenol and Motrin, other fever reducing techniques.
Significant increase in joint pain, headaches. Became light headed when standing. Significant brain fog impairing ability to work. Nausea, increased heartrate when doing mundane tasks (110 bpm walking vs normal of 70)  135 or higher when working (normal max 110).
Foot swelling with pain, redness, persisting and worsening for 5 weeks. Joint pain, scar tissue pain.
positive COVID-19 test with symptoms; sick; lung issues; high blood pressure; blood clots; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 52-years-old female patient received first dose of bnt162b2 (COMIRNATY, formulation: solution for injection, Batch/Lot Number: FC3180; Expiration Date: 31Oct2021), via an unspecified route of administration, administered in Arm Left on 10Aug2021 11:00 (at the age of 52-years-old) as dose 1, single for covid-19 immunisation. Medical history included covid-19 pneumonia (About 2 months before her Covid shot she was diagnosed with Covid Pneumonia but did not test positive for Covid) and diabetes mellitus from an unknown date and unknown if ongoing (Family Medical History Relevant to AE(s): Diabetes). There were no concomitant medications. The patient prior vaccination was reported as none. It was reported that the patient had the vaccine on 10Aug2021. She was very sick from the shot itself. She ended up testing positive for Covid on 21Aug2021. On unspecified date in 2021 experienced patient still was going to the doctor for lung issues and was sent to a cardiologist for blood clots and for high blood pressure. When she saw the Cardiologist, they x-rayed her lungs, and they were not in good shape. She had an appointment on 06Dec2021 with the cardiologist and they are hoping she won't be sick by then. Patient was still sick. She wanted to know about the side effects. The cardiologist said that blood clots are known to happen. She said that she had something in her blood that makes her susceptible to getting blood clots. She had been out of work since she got the shot. She only had one shot and was advised not to get the second one. Patient wanted to know is there any type of financial assistance for people who got sick after taking the vaccine. The patient required emergency room visit and physician office visit as a result of all events. The patient underwent lab tests and procedures which included sars-cov-2 test with positive on 21Aug2021 and x-rayed her lungs with not in good shape on an unspecified date. Outcome of the events sick was not resolved and all other events was unknown.  Conclusion: The complaint for lack of effect of the PFIZERBIONTECH COVID-19 VACCINE lot FC3180 was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, and an analysis of complaint history for the reported lot and product type. The final scope included the reported finished goods lot FC3180, fill lot EY546, and bulk formulation lot EP8650. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality. No root cause or CAPA were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications.  No follow-up attempts are needed. No further information is expected.
Pt tested positive for COVID 19 over a month after receiving second dose of COVID19 vaccine. Pt is asymptomatic
Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips; Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips; Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip; Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history information were provided.  Concomitant products included ESOMEPRAZOLE, AMITRIPTYLINE and CROMOGLICATE SODIUM (CROMOLYN [CROMOGLICATE SODIUM]) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, TASTE DISORDER (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), PARAESTHESIA ORAL (Funny taste in mouth and tongue started to feel tingly and tingly sensation in lips), HYPOAESTHESIA ORAL (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lip) and LIP SWELLING (Lip feel slightly numb, on and off, cycles through, lip swelling on bottom lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12_may-2021 contains non-significant information.
The morning after I received the vaccine I started with a headache and numbness tingling in my fingertips/toes. the headaches continued mostly all the time for 3 weeks and then they started to diminish. I went to the ER per my Dr's request because of the headaches and chest pain, numbness and tingling . They did an EKG and told me to see headache specialist or my pcp about the HA. Date of ER visit 12/29/21. Still have nightly headaches which have improved but numbness/tingling in hands/feet continues.
Patient was feeling nauseated in the morning prior to coming to work and prior to receiving vaccine. He had a banana thinking he would feel better. He then received the vaccine and felt progressively worse experiencing diarrhea, weakness, and malaise.
all described  as standard but lasted approximately 24   All times are Approximate Time of injection Onset of symptoms Redness and rash still present.
11:30 pm my son woke me with a red rash smaller than a dime. Checked it out gave benadryl went back to bed. Saturday,  June 27th my son woke up later than his normal wake up time complaining his arm is red. I took a marker circled area to see if it would spread gave benadryl, ice, and kept an eye on it. By 6:30 it was worse circling again called on call doctor she asked if the area on his right arm was warm to the touch as soon as I replied yes she advised bringing him immediately to a walk-in clinic or hospital. I had to drag him out to a hospital risking Covid to find out he had an allergic reaction to one or both the meningitis and tetanus vaccine. Then to top it off learn he had cellulitis from the injection site. They asked why did the nurse give both shots in the same arm. I replied I don't know believe because his writing arm is the left. They knew immediately what it was without running tests.
This spontaneous report as received from a nurse practitioner refers to a 26 years old female patient with no drug reactions/ allergies and no pertinent medical history who on 29-NOV-2012, was vaccinated with a dose of GARDASIL (IM(dose not reported) (lot # 672193/1524AA, Exp: 24-AUG-2014). No other co-suspects were reported. There was no concomitant medications. The nurse reported that the patient developed severe headaches with fever and slight dizziness 5 hours after getting a dose of GARDASIL. No treatment was given for the events. The outcome of the events was reported as recovered/resolved on 30-NOV-2012. No laboratory diagnostic studies were performed. The patient sought medical attention via calling the nurse practitioner. The relatedness for the events was unknown for GARDASIL. Additional information is not expected.
Extreme fatigue for two weeks, change in gait and hand tremors over that time - culminated into - inability to walk, hand tremors, drooping face and slurred, garbled speech - I thought he was having a stroke and called 911
Dtap 4, Prevnar 4 given left thigh at 12PM 6/22/05. No temp, no irritability. 8AM 6/23/05 left thigh swollen involves left knee warm to touch, no erythema and limp.
This spontaneous report as received from a Certified Medical Assistant (C.M.A.) refers to an unspecified number of unspecified patients of unknown gender and age. On an unknown date, an unspecified number of unspecified patients were vaccinated with doses of ROTATEQ vial (lot#, dose, frequency and route not provided) that were exposed to temperatures that were outside of the recommended temperature range. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.